These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7961157)

  • 1. WF11899A, B and C, novel antifungal lipopeptides. II. Biological properties.
    Iwamoto T; Fujie A; Nitta K; Hashimoto S; Okuhara M; Kohsaka M
    J Antibiot (Tokyo); 1994 Oct; 47(10):1092-7. PubMed ID: 7961157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FR209602 and related compounds, novel antifungal lipopeptides from coleophoma crateriformis no. 738. II. In vitro and in vivo antifungal activity.
    Kanasaki R; Abe F; Furukawa S; Yoshikawa K; Fujie A; Hino M; Hashimoto S; Hori Y
    J Antibiot (Tokyo); 2006 Mar; 59(3):145-8. PubMed ID: 16724454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal mechanism of FK463 against Candida albicans and Aspergillus fumigatus.
    Hatano K; Morishita Y; Nakai T; Ikeda F
    J Antibiot (Tokyo); 2002 Feb; 55(2):219-22. PubMed ID: 12003006
    [No Abstract]   [Full Text] [Related]  

  • 4. Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthase.
    Kurtz MB; Heath IB; Marrinan J; Dreikorn S; Onishi J; Douglas C
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1480-9. PubMed ID: 7979276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of cilofungin in vivo efficacy with its activity against Aspergillus fumigatus (1,3)-beta-D-glucan synthase.
    Beaulieu D; Tang J; Zeckner DJ; Parr TR
    FEMS Microbiol Lett; 1993 Apr; 108(2):133-7. PubMed ID: 8486238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arborcandins A, B, C, D, E and F, novel 1,3-beta-glucan synthase inhibitors: production and biological activity.
    Ohyama T; Kurihara Y; Ono Y; Ishikawa T; Miyakoshi S; Hamano K; Arai M; Suzuki T; Igari H; Suzuki Y; Inukai M
    J Antibiot (Tokyo); 2000 Oct; 53(10):1108-16. PubMed ID: 11132955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FR131535, a novel water-soluble echinocandin-like lipopeptide: synthesis and biological properties.
    Fujie A; Iwamoto T; Sato B; Muramatsu H; Kasahara C; Furuta T; Hori Y; Hino M; Hashimoto S
    Bioorg Med Chem Lett; 2001 Feb; 11(3):399-402. PubMed ID: 11212120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FR901469, a novel antifungal antibiotic from an unidentified fungus No.11243. II. In vitro and in vivo activities.
    Fujie A; Iwamoto T; Muramatsu H; Okudaira T; Sato I; Furuta T; Tsurumi Y; Hori Y; Hino M; Hashimoto S; Okuhara M
    J Antibiot (Tokyo); 2000 Sep; 53(9):920-7. PubMed ID: 11099225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antifungal activities of novel 1,3-beta-D-glucan synthase inhibitors. Part 2.
    Masubuchi K; Okada T; Kohchi M; Murata T; Tsukazaki M; Kondoh O; Yamazaki T; Satoh Y; Ono Y; Tsukaguchi T; Kobayashi K; Ono N; Inoue T; Horii I; Shimma N
    Bioorg Med Chem Lett; 2001 May; 11(10):1273-6. PubMed ID: 11392535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and cilofungin inhibition of solubilized Aspergillus fumigatus (1,3)-beta-D-glucan synthase.
    Beaulieu D; Tang J; Yan SB; Vessels JM; Radding JA; Parr TR
    Antimicrob Agents Chemother; 1994 May; 38(5):937-44. PubMed ID: 8067773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WF11899A, B and C, novel antifungal lipopeptides. I. Taxonomy, fermentation, isolation and physico-chemical properties.
    Iwamoto T; Fujie A; Sakamoto K; Tsurumi Y; Shigematsu N; Yamashita M; Hashimoto S; Okuhara M; Kohsaka M
    J Antibiot (Tokyo); 1994 Oct; 47(10):1084-91. PubMed ID: 7961156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antifungal activity and clinical efficacy of micafungin (funguard)].
    Ikeda F
    Nihon Ishinkin Gakkai Zasshi; 2005; 46(4):217-22. PubMed ID: 16282962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum differentially alters the antifungal properties of echinocandin drugs.
    Paderu P; Garcia-Effron G; Balashov S; Delmas G; Park S; Perlin DS
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2253-6. PubMed ID: 17420211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical diversity in lipopeptide antifungal antibiotics.
    Hino M; Fujie A; Iwamoto T; Hori Y; Hashimoto M; Tsurumi Y; Sakamoto K; Takase S; Hashimoto S
    J Ind Microbiol Biotechnol; 2001 Sep; 27(3):157-62. PubMed ID: 11780786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cilofungin (LY121019) inhibits Candida albicans (1-3)-beta-D-glucan synthase activity.
    Taft CS; Stark T; Selitrennikoff CP
    Antimicrob Agents Chemother; 1988 Dec; 32(12):1901-3. PubMed ID: 2977537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New antifungal agents].
    Miyazaki Y; Kawano S
    Jpn J Antibiot; 2002 Dec; 55(6):911-2. PubMed ID: 12664932
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization and optimization of in vitro assay conditions for (1,3)beta-glucan synthase activity from Aspergillus fumigatus and Candida albicans for enzyme inhibition screening.
    Wood RL; Miller TK; Wright A; McCarthy P; Taft CS; Pomponi S; Selitrennikoff CP
    J Antibiot (Tokyo); 1998 Jul; 51(7):665-75. PubMed ID: 9727393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caspofungin susceptibility in Aspergillus and non-Aspergillus molds: inhibition of glucan synthase and reduction of beta-D-1,3 glucan levels in culture.
    Kahn JN; Hsu MJ; Racine F; Giacobbe R; Motyl M
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2214-6. PubMed ID: 16723587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates.
    Park S; Kelly R; Kahn JN; Robles J; Hsu MJ; Register E; Li W; Vyas V; Fan H; Abruzzo G; Flattery A; Gill C; Chrebet G; Parent SA; Kurtz M; Teppler H; Douglas CM; Perlin DS
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3264-73. PubMed ID: 16048935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosis.
    Ikeda F; Wakai Y; Matsumoto S; Maki K; Watabe E; Tawara S; Goto T; Watanabe Y; Matsumoto F; Kuwahara S
    Antimicrob Agents Chemother; 2000 Mar; 44(3):614-8. PubMed ID: 10681327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.